Lysosomal enzyme defects and Parkinson disease

Neurology

Volumn 80, Issue 17, 2013, Pages 1544-1545

  Sharma, Nutan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA; LYSOSOME ENZYME; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELIN PHOSPHODIESTERASE 1, HUMAN;

DISEASE ASSOCIATION; DISEASE COURSE; EDITORIAL; ENZYME DEFECT; HUMAN; LYSOSOME STORAGE DISEASE; MUCOLIPIDOSIS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; TAY SACHS DISEASE; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; MUTATION; NOTE;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MUTATION; PARKINSON DISEASE; SPHINGOMYELIN PHOSPHODIESTERASE;

EID: 84878901392     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31828f1958     Document Type: Editorial

References (6)

1. Hornykiewicz O. The discovery of dopamine deficiency in the parkinsonian brain. J Neural Transm Suppl 2006;70:9-15.
2. Pan T, Kondo S, Le W, Jankovic J. The role of autophagylysosome pathway in neurodegeneration associated with Parkinson's disease. Brain 2008;131:1969-1978.
3. Ebrahimi-Fakhari D, Wahlster L, McLean PJ. Protein degradation pathways in Parkinson's disease: curse or blessing. Acta Neuropathol 2012;124:153-172.
4. Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R Z Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N Engl J Med 2004;351:1972-1977.
5. Gan-Or Z, Giladi N, Rozovski U, et al. Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset. Neurology 2008;70:2277-2283.
6. Gan-Or Z, Ozelius LJ, Bar-Shira A, et al. The p. L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease. Neurology 2013;80:1606-1610.